• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amedisys Inc - Common Stock (NQ:AMED)

100.99 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amedisys Inc - Common Stock

< Previous 1 2 3 4 5 Next >
Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023
March 13, 2023
 
Via Benzinga
What 10 Analyst Ratings Have To Say About Amedisys
March 13, 2023
 
Via Benzinga
Preview: Amedisys's Earnings
February 14, 2023
 
Via Benzinga
Where Amedisys Stands With Analysts
February 13, 2023
 
Via Benzinga
Amedisys Board of Directors Authorizes $100 Million Stock Repurchase Program
February 09, 2023
From Amedisys, Inc.
Via GlobeNewswire
Analyst Ratings for Amedisys
January 19, 2023
 
Via Benzinga
Expert Ratings for Amedisys
October 27, 2022
Within the last quarter, Amedisys (NASDAQ:AMED) has observed the following analyst ratings: 
Via Benzinga
Meta Platforms To Rally 34%? Here Are 10 Other Analyst Forecasts For Thursday
January 05, 2023
 
Via Benzinga
Amedisys Completes Home Health Joint Venture with the University of Arkansas for Medical Sciences
December 13, 2022
From Amedisys, Inc.
Via GlobeNewswire
Amedisys is Named One of the Most Responsible Companies of 2023 by Statista and Newsweek
December 08, 2022
From Amedisys, Inc.
Via GlobeNewswire
Amedisys Names Scott Ginn Acting Chief Operating Officer
November 22, 2022
From Amedisys, Inc.
Via GlobeNewswire
Expert Ratings for Amedisys
October 24, 2022
Amedisys (NASDAQ:AMED) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Where Amedisys Stands With Analysts
October 24, 2022
Analysts have provided the following ratings for Amedisys (NASDAQ:AMED) within the last quarter: 
Via Benzinga
Amedisys Statement on CY 2023 Home Health Final Rule
November 01, 2022
From Amedisys, Inc.
Via GlobeNewswire
Mastercard To $428? Plus This Analyst Slashes PT On Intel
October 31, 2022
Barclays cut the price target on Mastercard Incorporated (NYSE: MA) from $430 to $428. Barclays analyst Ramsey El-Assal maintained an Overweight rating on the stock. Mastercard shares fell 0.6% to... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 27, 2022
October 27, 2022
Upgrades 
Via Benzinga
6 Analysts Have This to Say About Amedisys
October 03, 2022
Amedisys (NASDAQ:AMED) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday
October 28, 2022
Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
October 27, 2022
  On Thursday, 111 stocks hit new 52-week lows. 
Via Benzinga
Why UserTesting Shares Are Trading Higher By Around 93%? Here Are 53 Stocks Moving In Thursday's Mid-Day Session
October 27, 2022
Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) gained 111% to $2.03 after the company announced it entered into a license agreement with Transcosmos Digital Technology for its Apromore process... 
Via Benzinga
Credit Suisse, Meta Platforms, Wolfspeed And Some Other Big Stocks Moving Lower On Thursday
October 27, 2022
U.S. stocks traded mixed, with the Dow Jones gaining more than 300 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Amedisys's Return on Invested Capital Overview
October 27, 2022
Pulled from Benzinga Pro data, Amedisys (NASDAQ:AMED) showed a loss in earnings since Q2, totaling $25.40 million. Sales, on the other hand, increased by 0.02% to $557.99 million during Q3. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 27, 2022
Gainers Clearside Biomedical (NASDAQ:CLSD) stock rose 27.3% to $1.35 during Thursday's pre-market session. The market value of their outstanding shares is at $81.2 million. 
Via Benzinga
Amedisys: Q3 Earnings Insights
October 26, 2022
Amedisys (NASDAQ:AMED) reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Amedisys missed estimated... 
Via Benzinga
Preview: Amedisys's Earnings
October 25, 2022
Amedisys (NASDAQ:AMED) is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the announcement. Analysts estimate that Amedisys will... 
Via Benzinga
University of Arkansas for Medical Sciences (UAMS) Announces a Partnership with Amedisys and Contessa, Creating a Comprehensive Care at Home Suite of Services
October 11, 2022
From Amedisys, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022
August 02, 2022
Upgrades 
Via Benzinga
What 9 Analyst Ratings Have To Say About Amedisys
July 28, 2022
Over the past 3 months, 9 analysts have published their opinion on Amedisys (NASDAQ:AMED) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Recap: Amedisys Q2 Earnings
July 27, 2022
Amedisys (NASDAQ:AMED) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Amedisys beat estimated earnings by... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2022
June 29, 2022
Upgrades 
Via Benzinga
< Previous 1 2 3 4 5 Next >
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap